Incyte (INCY) Return on Equity [ROE] (2013 - 2026)
Incyte (INCY) posted Return on Equity [ROE] of 26.95% for Q2 2026, up 4.73 percentage points from 22.22% a year earlier and up 0.41 percentage points from the prior quarter.
Incyte (INCY) Return on Equity [ROE] (2013 - 2026) Analysis & Trends
For FY2025, Incyte's Return on Equity [ROE] came in at 29.87%, up 29.11 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of +41.22 percentage points (FY2020 to FY2025).
- In prior years, Incyte's Return on Equity [ROE] was 0.76% in FY2024 (-11.75 pp), 12.50% in FY2023 (+4.13 pp), 8.37% in FY2022 (-21.36 pp) and 29.73% in FY2021 (+41.08 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q4 2021.
- On a year-over-year basis, Return on Equity [ROE] has increased in each of the last five quarters, with an average year-over-year change of +8.70 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 39.25 percentage points; the weakest was Q4 2022, with a drop of 19.49 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 26.54% (Q1 2026), 26.21% (Q4 2025) and 26.95% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Incyte | 24.39 Bn | 9.33 Bn | 1.57 Bn | 26.95% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.95% |
| Mar 31, 2026 | 26.54% |
| Dec 31, 2025 | 26.21% |
| Sep 30, 2025 | 26.95% |
| Jun 30, 2025 | 22.22% |
| Mar 31, 2025 | 0.60% |
| Dec 31, 2024 | 0.99% |
| Sep 30, 2024 | 1.05% |
| Jun 30, 2024 | 2.32% |
| Mar 31, 2024 | 14.09% |
| Dec 31, 2023 | 11.81% |
| Sep 30, 2023 | 8.79% |
| Jun 30, 2023 | 7.96% |
| Mar 31, 2023 | 7.34% |
| Dec 31, 2022 | 7.93% |
| Sep 30, 2022 | 21.08% |
| Jun 30, 2022 | 23.78% |
| Mar 31, 2022 | 24.45% |
| Dec 31, 2021 | 27.42% |
| Sep 30, 2021 | 17.57% |
Incyte Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INCY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();